{
  "last_update": "2025-10-02T06:22:34.058Z",
  "stocks": [
    {
      "ticker": "CVS",
      "timestamp": "2025-10-02T06:22:25.141Z",
      "raw_text": "\n\nSkip to contentNo usernameSet UsernameProfileAccount SettingsManage Emails & AlertsSaved ArticlesRead ArticlesMy NotesSign outHomeCustomize my topicsAnalysisNewsMarket DataInvesting GroupsExplore Investing GroupsAlpha Picks1PortfoliosPortfolio 10.34%Create Portfolio+Saved ScreensCreate Screen+Find & CompareTop StocksTop ETFsStock ScreenerETF ScreenerComparisonsUpgrade To PROExplore Alpha PicksHome page Seeking Alpha - Power to InvestorsSearch for Symbols, analysts, keywordsCVS  CVS Health CorporationAnalyze With AIsymbol alertsFollow166.48K followers$76.871.48 (+1.96%)4:00 PM 10/01/25NYSE |  $USD | Post-Market: $76.87 +0.00 (+0.00%) 7:58 PMAnalyze With AISummaryRatingsFinancialsEarningsDividendsValuationGrowthProfitabilityMomentumPeersOptionsCharting{\"@context\":\"https://schema.org/\",\"@type\":\"WebPage\",\"name\":\"CVS Health Corporation (CVS) Stock Price, Quote, News & Analysis\",\"description\":\"A high-level overview of CVS Health Corporation (CVS) stock. View (CVS) real-time stock price, chart, news, analysis, analyst reviews and more.\",\"mainEntityOfPage\":\"https://seekingalpha.com/symbol/CVS\",\"publisher\":{\"@context\":\"http://schema.org\",\"@type\":\"Organization\",\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"244 5th Ave\",\"addressLocality\":\"New York\",\"addressRegion\":\"NY\",\"postalCode\":\"10001\",\"addressCountry\":\"US\"},\"alternateName\":[\"SeekingAlpha\",\"SA\"],\"brand\":[{\"@type\":\"Brand\",\"name\":\"Seeking Alpha Premium\",\"url\":\"https://seekingalpha.com/subscriptions/premium\"},{\"@type\":\"Brand\",\"name\":\"Seeking Alpha PRO\",\"url\":\"https://seekingalpha.com/subscriptions\"},{\"@type\":\"Brand\",\"name\":\"Alpha Picks\",\"url\":\"https://seekingalpha.com/subscriptions/alpha-picks\"},{\"@type\":\"Brand\",\"name\":\"Investing Groups by Seeking Alpha\",\"url\":\"https://seekingalpha.com/marketplace/directory\"}],\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+1-347-509-6837\",\"email\":\"subscriptions@seekingalpha.com\"},\"description\":\"Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally.\",\"email\":\"subscriptions@seekingalpha.com\",\"image\":\"https://seekingalpha.com/samw/static/images/OrganizationLogo.b472cbb2d.png\",\"foundingDate\":\"2004\",\"legalName\":\"Seeking Alpha\",\"logo\":{\"@type\":\"ImageObject\",\"height\":60,\"url\":\"https://seekingalpha.com/samw/static/images/PublisherLogo.1bcd2753c.png\",\"width\":360},\"name\":\"Seeking Alpha\",\"sameAs\":[\"https://www.facebook.com/Seekingalpha\",\"https://www.youtube.com/channel/UC9ZGkLwawKeG5C0Dt9FS-lQ\",\"https://www.linkedin.com/company/seeking-alpha/\",\"https://www.wikidata.org/wiki/Q3477676\",\"https://www.instagram.com/seekingalpha/\",\"https://x.com/SeekingAlpha\",\"https://www.tiktok.com/@seekingalphaofficial\",\"https://open.spotify.com/show/05uLjJxkVgQsRk8LWLCLpx\",\"https://podcasts.apple.com/us/podcast/wall-street-breakfast/id1358381502\"],\"slogan\":\"Inform. Empower. Invest.\",\"telephone\":\"+1-347-509-6837\",\"url\":\"https://seekingalpha.com\"},\"about\":{\"@context\":\"http://schema.org\",\"@type\":\"Corporation\",\"@id\":\"https://seekingalpha.com/symbol/CVS#corporation\",\"name\":\"CVS Health Corporation\",\"logo\":\"https://static.seekingalpha.com/cdn/s3/company_logos/mark_vector_light/CVS.svg\",\"description\":\"CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.\",\"tickerSymbol\":\"NYSE CVS\"}}AllAllAnalysisAnalysisCommentsCommentsNewsNewsTranscripts & InsightsTranscripts & InsightsSEC FilingsSEC FilingsPress ReleasesPress ReleasesRelated AnalysisRelated Analysis7 Investing Groups Covering CVS »ChartsAdv Chart1D5D1M6MYTD1Y5Y10YMAXCVS Health Corporation price and volumeCombination chart with 2 data series.Chart represents CVS Health Corporation \n price and volume over 1Y periodThe chart has 2 X axes displaying  Time, and Time.The chart has 2 Y axes displaying  symbol price, and symbol volume..Created with Highcharts 12.4.0Oct 2025Aug 2025Jun 2025Apr 2025Feb 2025Dec 20244050607080End of interactive chart.52 Week Range43.5677.54Day Range75.2577.54EPS (FWD)6.36PE (FWD)11.84Div Rate (FWD)$2.66Yield (FWD)3.53%Short Interest1.86%Market Cap$95.62BVolume11,095,158Prev. Close$75.39Expand For Key Data »Ratings Summary?NameRatingScoreSA AnalystsBuyRating: Buy3.80Wall StreetBuyRating: Buy4.42QuantHoldRating: Hold3.48Ratings Summary?SA AnalystsBuy Wall StreetBuy QuantHold GradeNow3M ago6M agoValuationA-AA-GrowthD-FD+ProfitabilityA+A+A+MomentumB+A-ARevisionsB+AD+Quant Ranking?SectorHealth CareIndustryHealth Care ServicesRanked Overall747 out of 4313Ranked in Sector139 out of 971Ranked in Industry14 out of 49Quant Ratings Beat The Market »My NotesAdd NoteLatest HeadlinesAllAllAnalysisAnalysisNewsNewsUnitedHealth, CVS Health, Humana scale back Medicare Advantage offeringsSA NewsYesterday, 11:56 AM44 CommentsSaveCVS PBM Caremark exploring $200 copay for Novo Nordisk's Wegovy - reportSA NewsYesterday, 11:43 AM12 CommentsSaveMedicare Advantage enrollments expected to drop next yearSA NewsSat, Sep. 2796 CommentsSavePBMs reportedly eyeing changes to business conduct to avert regulatory scrutinySA NewsThu, Sep. 2511 CommentsSaveRFK Jr. orders FDA investigation into safety of abortion pill mifepristoneSA NewsThu, Sep. 2548 CommentsSaveCVS Health: A Deeply Undervalued Giant Investors Keep IgnoringBuyDaniel SchönbergerThu, Sep. 256 CommentsSaveCVS Health falls after six sessions of gainSA NewsWed, Sep. 241 CommentSaveCVS subsidiary Omnicare initiates Chapter 11 in wake of improper billing lawsuitSA NewsMon, Sep. 229 CommentsSaveCVS declares $0.665 dividendSA NewsThu, Sep. 182 CommentsSaveU.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meetingSA NewsWed, Sep. 1745 CommentsSaveMore News And Analysis »SeasonalityDisplays mean and median monthly returns for CVS in order to identify seasonal patterns.ChartBar chart with 2 data series.View as data table, ChartThe chart has 1 X axis displaying categories. The chart has 1 Y axis displaying Values. Data ranges from 0 to 0.Created with Highcharts 12.4.0ValuesMedianMeanEnd of interactive chart.YearJanFebMarAprMayJunJulAugSepOctNovDecYearJanFebMarAprMayJunJulAugSepOctNovDec+ Seasonality Stocks To Home PagePeople Also FollowSymbolLast PriceChangeBMYBristol-Myers Squibb Company47.43Post. 48.005.17%1.20%ABBVAbbVie Inc.244.38Post. 243.855.55%-0.22%JNJJohnson & Johnson186.05Post. 186.000.34%-0.03%PFEPfizer Inc.27.21Post. 27.396.79%0.66%MRKMerck & Co., Inc.90.13Post. 91.007.39%0.97%CompareDividend Grades?GradeNow3M ago6M agoSafetyB+B+B+GrowthC+CD-YieldA-AA-ConsistencyBBB+Dividend Grades Beat The Market »Bulls SayBears SayCompany ProfileCVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.More...Full Company Profile »RevenueMore On Revenue »Earnings Per ShareMore On Earnings »Earnings EstimatesEarnings RevisionsB+FY1 Up Revisions26FY1 Down Revisions13% Down97% UpMore On Earnings Revisions »ValuationA-P/E Non-GAAP (FWD)11.84P/E GAAP (TTM)21.00Price/Book (TTM)1.23EV/Sales (TTM)0.43EV/EBITDA (TTM)11.76More On Valuation »GrowthProfitabilityA+Gross Profit Margin13.30%EBIT Margin2.43%Net Income Margin1.18%Return on Equity5.88%Return on Assets1.75%More On Profitability »MomentumCapital StructureMarket Cap$95.62BTotal Debt$82.72BCash$14.17BOther$172.00MEnterprise Value$164.34BTrading DataVolume11.10MAverage Volume (3 months)7.55MPrevious Close75.39Open75.30Shares Outstanding (Ticker)1.27BDividendsDividend Yield (FWD)3.53%Annual Payout (FWD)$2.66Payout Ratio41.96%5 Year Growth Rate (CAGR)5.87%Years of Growth3 YearsLatest Announced Dividend$0.67Ex-Dividend Date10/23/2025Payout Date11/3/2025FrequencyQuarterlyMore On Dividends »Dividend Growth HistoryMore On Dividend Growth »OwnershipPeersRiskShort Interest1.86%Shares Short23.62MDays to Cover2.7724M Beta0.51Altman Z Score2.12TechnicalsTitle10D SMA50D SMA200D SMASimple Moving Average75.2769.4663.42Last Price vs SMA+0.16%+8.54%+18.88%More On Moving Averages »TranscriptsCVS Health Corporation (CVS) Q2 2025 Earnings Call TranscriptSA TranscriptsWed, Aug. 06SaveCVS Health (CVS) Q1 2025 Earnings Call TranscriptSA TranscriptsThu, May 01SaveCVS Health (CVS) Q4 2024 Earnings Call TranscriptSA TranscriptsWed, Feb. 12SaveCVS Health Corporation (CVS) Wolfe 2024 Healthcare Conference (Transcript)SA TranscriptsTue, Nov. 19, 2024SaveCVS Health (CVS) Q3 2024 Earnings Call TranscriptSA TranscriptsWed, Nov. 06, 2024SaveSee All Transcripts »Investor PresentationsCVS Health Corporation 2025 Q2 - Results - Earnings Call PresentationWed, Aug. 06SaveCVS Health Corporation 2024 Q1 - Results - Earnings Call PresentationWed, May 01, 2024SaveCVS Health Corporation 2023 Q4 - Results - Earnings Call PresentationWed, Feb. 07, 2024SaveJ.P. Morgan 42nd Annual Healthcare ConferenceMon, Jan. 08, 2024SaveCVS Health Corporation 2023 Q3 - Results - Earnings Call PresentationWed, Nov. 01, 20231 CommentSaveSee All Investor Presentations »SEC FilingsType:AllCVS Health Corporation (CVS) - 8-K - Current reportSEC FilingsMon, Sep. 22CVS Health Corporation (CVS) - 4 - Statement of Changes in Beneficial OwnershipSEC FilingsTue, Sep. 02CVS Health Corporation (CVS) - 4 - Statement of Changes in Beneficial OwnershipSEC FilingsTue, Sep. 02CVS Health Corporation (CVS) - 4 - Statement of Changes in Beneficial OwnershipSEC FilingsFri, Aug. 29CVS Health Corporation (CVS) - 144 - Report of proposed sale of securitiesSEC FilingsTue, Aug. 19See All SEC Filings »Press ReleasesSee All Press Releases »Income StatementBalance SheetCash Flow StatementLong Term SolvencyTotal Debt / Equity (MRQ)106.67%Total Debt / Capital (MRQ)51.61%LT Debt / Equity (MRQ)92.35%LT Debt / Total Capital (MRQ)44.68%Total Liabilities / Total Assets (MRQ)69.98%Looking For The Perfect Gift?You can now buy 1 year of Seeking Alpha Premium for whomever you like.Gift Premium7 Investing Groups Covering CVS »Add Custom NotesRatings Summary?NameRatingScoreSA AnalystsBuyRating: Buy3.80Wall StreetBuyRating: Buy4.42QuantHoldRating: Hold3.48Quant Ranking?SectorHealth CareIndustryHealth Care ServicesRanked Overall747 out of 4313Ranked in Sector139 out of 971Ranked in Industry14 out of 49Quant Ratings Beat The Market »Dividend Grades?GradeNow3M ago6M agoSafetyB+B+B+GrowthC+CD-YieldA-AA-ConsistencyBBB+Dividend Grades Beat The Market »Looking For The Perfect Gift?You can now buy 1 year of Seeking Alpha Premium for whomever you like.Gift PremiumSeeking Alpha - Power to InvestorsPower to InvestorsFollow usDownload appAccountAccount SettingsManage My PortfolioPrivacyCreate PortfolioAlert PreferencesSubscriptionsPremium & ProGroup SubscriptionsAlpha PicksAbout Alpha PicksFREE NewslettersInvesting GroupsLearn About Investing GroupsMost PopularFree TrialsTop RatedDividend InvestingValue InvestingOptions TradingGrowth StocksBiotech InvestingTech StocksQuantitative InvestingLearnInvesting ResourcesInvesting EducationInvesting StrategiesRetirement InvestingStock Market SectorsStock Market Holidays & HoursAfter Hours TradingPortfolio ManagementCryptocurrencyDividend InvestingPortfolio StrategyFixed IncomeRetirementIPO'sPodcastsVideo HubEventsEditors' PicksStock AnalysisStock IdeasLong IdeasStock Upgrades & DowngradesEditors' PicksQuick Picks & ListsEmerging MarketsStock ScreenerStocks by QuantTop StocksTop Quant Dividend StocksHigh Dividend Yield StocksTop Dividend StocksETFs & FundsETF ScreenerETF AnalysisETF GuideMutual FundsClosed End FundsEditors' PicksDividendsDividend Stock NewsREITsDividend IdeasDividend StrategyDividend Quick PicksEditors' PicksAnalysis by SectorEnergyCommunication ServicesReal EstateConsumer StaplesTechBasic MaterialsHealthcareConsumerUtilitiesFinancialsIndustrialsStock Comparison ToolsFAANG StocksGold ETFsCash EquivalentsBig Bank StocksBig Pharma StocksRetail StocksTop IndexesDow JonesS&P 500NasdaqGoldBitcoinMarket OutlookToday's MarketUS EconomyGold & Precious MetalsCommoditiesForexEditors' PicksCryptocurrencyMarket DataBond ETFsCommodity ETFsCountry ETFsCurrency ETFsDividend ETFsEmerging Market ETFsGlobal and Regional ETFsGrowth vs. Value ETFsMarket Cap ETFsReal Estate ETFsSector ETFsETF StrategiesSmart BetaThemes & Subsectors ETFsCryptocurrencyMarket NewsTop NewsTrending NewsOn the MoveMarket PulseGlobal MarketsNotable CallsBuybacksCommoditiesCryptocurrencyDebt/Share IssuanceDividends - StocksDividends - FundsGuidanceIPOsSPACsBudget & RegulationJobs & EmploymentPoliticsM&AUS EconomyWall Street BreakfastNews by SectorConsumerEnergyFinancialsHealthcareTechEarningsEarnings CalendarEarnings NewsEarnings AnalysisEarnings Calls TranscriptsContact usSubscription Support: 1-347-509-6837Contact UsAbout UsGroup SubscriptionsAffiliate ProgramCareersSitemapRSS FeedTerms Of UsePrivacyMarket Data Sources© 2025 Seeking AlphaBackVirtual Analyst ReportGenerated on 9/25/2025 1:42 AMFollow CVSCVS - CVS Health CorporationHoldQuant RatingMarket Cap$95.62BEPS Growth (FWD)-6.45%P/E (FWD)11.84IndustryHealth Care ServicesDividend Yield (FWD)3.53%Dividend FrequencyQuarterlyEx-Dividend Date (Last)10/23/2025Annual Payout (FWD)$2.66Copy URLSharePrintCompany Description\nCVS Health Corporation, based in Woonsocket, Rhode Island, is a prominent health solutions company in the United States, offering a wide range of services through its Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. Founded in 1996, the company has evolved from its origins as CVS Caremark Corporation to become a diversified healthcare leader.\n\nThe Health Care Benefits segment provides insurance products and related services, including medical, pharmacy, dental, and behavioral health plans, as well as Medicare Advantage and Medicaid management services. This segment caters to various customers, including employer groups, individuals, and government-sponsored plans.\n\nThe Health Services segment manages pharmacy benefits, offering solutions such as plan design, formulary management, and specialty pharmacy services. It also operates medical clinics and provides virtual and in-home care.\n\nThe Pharmacy & Consumer Wellness segment focuses on retail pharmacy services, selling both prescription and over-the-counter medications, health products, and personal care items. CVS operates over 9,000 retail locations, providing extensive accessibility to its services.\n\nThrough strategic acquisitions, such as Aetna in 2018 and Oak Street Health in 2023, CVS has expanded its footprint in health insurance and value-based care. The company is committed to integrating healthcare delivery and improving health outcomes through technology-driven solutions and a national network of community health destinations.\nCompetitors and Unique Value\nCVS Health faces competition from several major players in the healthcare and retail pharmacy sectors. Among its primary competitors are:\nUnitedHealth GroupCigna CorporationWalgreens Boots Alliance\nCVS Health's unique value proposition lies in its integrated healthcare model, which combines insurance, pharmacy services, and retail health into a cohesive ecosystem. The company's vast network of retail locations and clinics offers convenient access to health services nationwide. Additionally, CVS's strategic investments in value-based care through acquisitions like Oak Street Health demonstrate its commitment to improving patient outcomes while managing costs effectively.\nSeeking Alpha Quant Rating Explanation\nCVS is rated Hold. The company demonstrates a strong profitability profile and significant stock momentum. However, its growth metrics show challenges, while its valuation appears attractive. Analyst revisions are predominantly positive, suggesting some optimism about future performance.\nValuationA-GrowthD-ProfitabilityA+MomentumB+RevisionsB+Sector Metrics Comparative Analysis:Valuation: CVS trades at an appealing valuation with a P/E of 12, significantly lower than the sector median of 18, indicating a discounted stock. Additionally, the forward PEG of 0.62 is a 65% discount to the sector, suggesting underpricing. However, its Price to Book ratio of 1.27 is much lower than the sector median of 2.83, further highlighting its relative undervaluation.\nGrowth: The company faces growth challenges, with Year-over-Year EPS declining by 36%, far below the sector's growth rate of 16%. Additionally, forward EBITDA growth is projected to decrease by 3%, compared to a sector increase of 8%, indicating a slowing growth trajectory.\nProfitability: CVS boasts high profitability with a Net Income Margin of 1.18%, significantly outperforming the sector median. Its asset turnover ratio of 1.50 is also substantially higher than the sector's 0.45, underscoring efficient asset utilization.\nMomentum: CVS exhibits strong stock momentum, with a one-year price performance of 33%, far surpassing the sector median of -12%. This indicates bullish sentiment and strong investor confidence in the company's prospects.\nRevisions: Analyst revisions are encouraging, with 26 upward EPS revisions and only 1 downward in the last three months, suggesting an optimistic outlook for future earnings.\n\nIn summary, CVS's stock momentum and profitability are commendable, providing a solid foundation. However, growth concerns temper the overall outlook, resulting in a Hold rating, reflective of expectations for the stock to perform in line with its peers.\nPositives raised by analysts on Seeking Alpha\n\n\nCVS Health is seen as deeply undervalued, with intrinsic value calculations suggesting a significant upside potential, indicating the stock could be a good investment for those seeking long-term growth. Read more\n\n\nThe company's strong performance in the retail pharmacy segment, despite industry challenges, highlights its resilience and ability to adapt to changing market conditions. Read more\n\n\nCVS Health's focus on value-based care and strategic acquisitions positions it well for future growth, as it continues to innovate and expand its healthcare services. Read moreRead more analysis on CVS Concerns raised by analysts on Seeking Alpha\n\n\nCVS faces significant regulatory and political risks, particularly in its Medicare Advantage and Pharmacy Benefit Management segments, which could impact its profitability and operational stability. Read more\n\n\nThe company's high debt levels, resulting from recent acquisitions, pose a financial risk, potentially limiting its ability to invest in new growth opportunities or weather economic downturns. Read more\n\n\nCVS's stock price has remained relatively stagnant over the past decade, indicating challenges in convincing investors of its long-term growth potential and strategic direction. Read moreRead more analysis on CVSMore on CVSInvesting Groups discussing CVSTop rated stocks in the industryRead more analysis on CVSAbout Seeking Alpha’s Virtual Analyst Reports\n  This report integrates all the crowd-sourced wisdom of Seeking Alpha analysis and our proprietary quant model into one easy-to-read report.\n\n  AI tools frequently struggle to provide reliable guides for investors, because the sources on which they base their answers or recommendations lack a proven track record in stock picking, and are frequently written by journalists or marketers rather than investors.\n\n  In contrast, Seeking Alpha uses generative AI to create Virtual Analyst Reports exclusively from our own trusted, editor-approved content and financial data. We use unique sources exclusive to Seeking Alpha. These sources have excellent stock picking track records, and are produced by investors, for investors.\n\n  Our main sources are Seeking Alpha’s quant ratings and analyst articles. Both of these have long track records of strong stock picking performance. Here’s the track record of our quant ratings. And here’s the track record of the ratings from our analysts’ articles, which illustrates “the wisdom of the crowd” at the heart of Seeking Alpha’s crowd-sourced investment analysis.\nTop Quant Rating328%SA Analyst171%S&P 50093%ChartLine chart with 3 lines.View as data table, ChartThe chart has 1 X axis displaying Time. Data ranges from 2019-10-23 20:00:00 to 2025-09-29 20:00:00.The chart has 1 Y axis displaying values. Data ranges from -35.51337812243312 to 327.67001885012866.Created with Highcharts 12.4.0Apr. 23, 2020Apr. 21, 2021Apr. 18, 2022Apr. 17, 2023Apr. 15, 2024Apr. 14, 2025-60%-30%0%30%60%90%120%150%180%210%240%270%300%330%360%End of interactive chart.\n  The result is that our Virtual Analyst Reports share the same predictive strength as our Quant ratings, and summarize valuable insights from Seeking Alpha analysts, who have also beaten the market as a group.\nYour feedback matters to usSubmitVirtual Analyst Report FAQ >>Virtual Analyst Report FAQ >>Disclosure: The Virtual Analyst Report is an up-to-date easy-to-read summary compilation of content available on the Seeking Alpha website, including research analysis created by third parties and ratings set by the Quant system. The summary is written by a commercial general-purpose language model (LLM), and has not been curated or reviewed by editors. Due to the inherent limitations in using AI tools, please consider the probability of error. The accuracy, completeness or timeliness of the report cannot be guaranteed. It is generated on the date indicated at the top of the page, based on the content available on the Seeking Alpha website at that time, and is automatically updated as new content becomes available on the site. It offers a concise overview of a company, an explanation of the stock's Quant Ratings and a short summary of bullish and bearish research analysis available on Seeking Alpha with respect to such stock. Research analysis is automatically selected by the AI tool based on relevant dates and overall analyst ratings. The report does not consider any other information or perform any independent analysis.\n\n        The Virtual Analyst Report is intended for informational purposes only and should not be construed as financial advice or a recommendation for any investment strategy. Any views or opinions expressed may not reflect those of Seeking Alpha as a whole. Seeking Alpha does not take account of your objectives or financial situation and does not offer any personalized investment advice. Analysts are third parties that include both professional and individual investors who may not be licensed or certified by any institute or regulatory body. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.\n\n        We encourage you to provide your feedback on the usefulness of this summary using the feedback input field above.BackGenerated 09/25/25CVS - CVS Health CorporationHoldGenerated 09/25/25To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.\n\n\n<iframe height=\"0\" src=\"https://www.googletagmanager.com/ns.html?id=GTM-MSK9R8B\" style=\"display:none;visibility:hidden\" title=\"google-tag-manager\" width=\"0\"></iframe><img alt=\"\" src=\"/_sa_track/samw/noscript?noscript[disabled]=true\">\n\n\n\n\n\n\n\n\n  \n  \n  \n  \n  \n  \n  \n  \n\n\n!function(b,e,f,g,a,c,d){b.fbq||(a=b.fbq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._fbq||(b._fbq=a),a.push=a,a.loaded=!0,a.version=\"2.0\",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,\"script\",\"https://connect.facebook.net/en_US/fbevents.js\");fbq(\"init\",\"228550053985270\");fbq(\"track\",\"PageView\");\n<img height=\"1\" width=\"1\" style=\"display:none\" src=\"https://www.facebook.com/tr?id=228550053985270&amp;ev=PageView&amp;noscript=1\">\n\n!function(b,e,f,g,a,c,d){b.saq||(a=b.saq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._saq||(b._saq=a),a.push=a,a.loaded=!0,a.version=\"1.0\",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,\"script\",\"https://tags.srv.stackadapt.com/events.js\");saq(\"ts\",\"blaF1FtON6tR_IxV4MjJrA\");!function(a,b){var e=\"0024c043618e075e435f95a5ef5ef386f5\";if(a.obApi)b=function(d){return Object.prototype.toString.call(d)===\"[object Array]\"?d:[d]},a.obApi.marketerId=b(a.obApi.marketerId).concat(b(e));else{var c=a.obApi=function(){c.dispatch?c.dispatch.apply(c,arguments):c.queue.push(arguments)};c.version=\"1.1\";c.loaded=!0;c.marketerId=e;c.queue=[];a=b.createElement(\"script\");a.async=!0;a.src=\"//amplify.outbrain.com/cp/obtp.js\";a.type=\"text/javascript\";b=b.getElementsByTagName(\"script\")[0];b.parentNode.insertBefore(a,\nb)}}(window,document);obApi(\"track\",\"PAGE_VIEW\");\n",
      "url": "https://seekingalpha.com/symbol/CVS/virtual_analyst_report"
    },
    {
      "ticker": "MSFT",
      "timestamp": "2025-10-02T06:22:32.057Z",
      "raw_text": "\n\nSkip to contentNo usernameSet UsernameProfileAccount SettingsManage Emails & AlertsSaved ArticlesRead ArticlesMy NotesSign outHomeCustomize my topicsAnalysisNewsMarket DataInvesting GroupsExplore Investing GroupsAlpha Picks1PortfoliosPortfolio 10.34%Create Portfolio+Saved ScreensCreate Screen+Find & CompareTop StocksTop ETFsStock ScreenerETF ScreenerComparisonsUpgrade To PROExplore Alpha PicksHome page Seeking Alpha - Power to InvestorsSearch for Symbols, analysts, keywordsMSFT  Microsoft CorporationAnalyze With AINewsymbol alertsFollow1.3M followers$519.711.76 (+0.34%)4:00 PM 10/01/25NASDAQ |  $USD | Post-Market: $519.65 -0.06 (-0.01%) 7:59 PMAnalyze With AINewSummaryRatingsFinancialsEarningsDividendsValuationGrowthProfitabilityMomentumPeersOptionsCharting{\"@context\":\"https://schema.org/\",\"@type\":\"WebPage\",\"name\":\"Microsoft Corporation (MSFT) Stock Price, Quote, News & Analysis\",\"description\":\"A high-level overview of Microsoft Corporation (MSFT) stock. View (MSFT) real-time stock price, chart, news, analysis, analyst reviews and more.\",\"mainEntityOfPage\":\"https://seekingalpha.com/symbol/MSFT\",\"publisher\":{\"@context\":\"http://schema.org\",\"@type\":\"Organization\",\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"244 5th Ave\",\"addressLocality\":\"New York\",\"addressRegion\":\"NY\",\"postalCode\":\"10001\",\"addressCountry\":\"US\"},\"alternateName\":[\"SeekingAlpha\",\"SA\"],\"brand\":[{\"@type\":\"Brand\",\"name\":\"Seeking Alpha Premium\",\"url\":\"https://seekingalpha.com/subscriptions/premium\"},{\"@type\":\"Brand\",\"name\":\"Seeking Alpha PRO\",\"url\":\"https://seekingalpha.com/subscriptions\"},{\"@type\":\"Brand\",\"name\":\"Alpha Picks\",\"url\":\"https://seekingalpha.com/subscriptions/alpha-picks\"},{\"@type\":\"Brand\",\"name\":\"Investing Groups by Seeking Alpha\",\"url\":\"https://seekingalpha.com/marketplace/directory\"}],\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+1-347-509-6837\",\"email\":\"subscriptions@seekingalpha.com\"},\"description\":\"Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally.\",\"email\":\"subscriptions@seekingalpha.com\",\"image\":\"https://seekingalpha.com/samw/static/images/OrganizationLogo.b472cbb2d.png\",\"foundingDate\":\"2004\",\"legalName\":\"Seeking Alpha\",\"logo\":{\"@type\":\"ImageObject\",\"height\":60,\"url\":\"https://seekingalpha.com/samw/static/images/PublisherLogo.1bcd2753c.png\",\"width\":360},\"name\":\"Seeking Alpha\",\"sameAs\":[\"https://www.facebook.com/Seekingalpha\",\"https://www.youtube.com/channel/UC9ZGkLwawKeG5C0Dt9FS-lQ\",\"https://www.linkedin.com/company/seeking-alpha/\",\"https://www.wikidata.org/wiki/Q3477676\",\"https://www.instagram.com/seekingalpha/\",\"https://x.com/SeekingAlpha\",\"https://www.tiktok.com/@seekingalphaofficial\",\"https://open.spotify.com/show/05uLjJxkVgQsRk8LWLCLpx\",\"https://podcasts.apple.com/us/podcast/wall-street-breakfast/id1358381502\"],\"slogan\":\"Inform. Empower. Invest.\",\"telephone\":\"+1-347-509-6837\",\"url\":\"https://seekingalpha.com\"},\"about\":{\"@context\":\"http://schema.org\",\"@type\":\"Corporation\",\"@id\":\"https://seekingalpha.com/symbol/MSFT#corporation\",\"name\":\"Microsoft Corporation\",\"logo\":\"https://static.seekingalpha.com/cdn/s3/company_logos/mark_vector_light/MSFT.svg\",\"description\":\"Microsoft Corporation develops and supports software, services, devices, and solutions worldwide. The company’s Productivity and Business Processes segment offers Microsoft 365 Commercial, Enterprise Mobility + Security, Windows Commercial, Power BI, Exchange, SharePoint, Microsoft Teams, Security and Compliance, and Copilot; Microsoft 365 Commercial products, such as Windows Commercial on-premises and Office licensed services; Microsoft 365 Consumer products and cloud services, such as Microsoft 365 Consumer subscriptions, Office licensed on-premises, and other consumer services; LinkedIn; Dynamics products and cloud services, such as Dynamics 365, cloud-based applications, and on-premises ERP and CRM applications. Its Intelligent Cloud segment provides Server products and cloud services, such as Azure and other cloud services, GitHub, Nuance Healthcare, virtual desktop offerings, and other cloud services; Server products, including SQL and Windows Server, Visual Studio and System Center related Client Access Licenses, and other on-premises offerings; Enterprise and partner services, including Enterprise Support and Nuance professional Services, Industry Solutions, Microsoft Partner Network, and Learning Experience. The company’s Personal Computing segment provides Windows and Devices, such as Windows OEM licensing and Devices and Surface and PC accessories; Gaming services and solutions, such as Xbox hardware, content, and services, first- and third-party content Xbox Game Pass, subscriptions, and Cloud Gaming, advertising, and other cloud services; search and news advertising services, such as Bing and Copilot, Microsoft News and Edge, and third-party affiliates. It sells its products through OEMs, distributors, and resellers; and online and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.\",\"tickerSymbol\":\"NASDAQ MSFT\"}}AllAllAnalysisAnalysisCommentsCommentsNewsNewsTranscripts & InsightsTranscripts & InsightsSEC FilingsSEC FilingsPress ReleasesPress ReleasesRelated AnalysisRelated Analysis16 Investing Groups Covering MSFT »ChartsAdv Chart1D5D1M6MYTD1Y5Y10YMAXMicrosoft Corporation price and volumeCombination chart with 2 data series.Chart represents Microsoft Corporation \n price and volume over 1Y periodThe chart has 2 X axes displaying  Time, and Time.The chart has 2 Y axes displaying  symbol price, and symbol volume..Created with Highcharts 12.4.0Oct 2025Aug 2025Jun 2025Apr 2025Feb 2025Dec 2024350400450500550End of interactive chart.52 Week Range344.79555.45Day Range511.69520.51EPS (FWD)15.55PE (FWD)33.30Div Rate (FWD)$3.64Yield (FWD)0.70%Short Interest0.88%Market Cap$3.85TVolume22,632,336Prev. Close$517.95Expand For Key Data »Ratings Summary?NameRatingScoreSA AnalystsBuyRating: Buy4.00Wall StreetStrong BuyRating: Strong Buy4.74QuantHoldRating: Hold3.48Ratings Summary?SA AnalystsBuy Wall StreetStrong Buy QuantHold GradeNow3M ago6M agoValuationFFFGrowthC-C-D+ProfitabilityA+A+A+MomentumB-BC+RevisionsBB+B+Quant Ranking?SectorInformation TechnologyIndustrySystems SoftwareRanked Overall745 out of 4313Ranked in Sector98 out of 540Ranked in Industry9 out of 46Quant Ratings Beat The Market »My NotesAdd NoteLatest HeadlinesAllAllAnalysisAnalysisNewsNewsMicrosoft Extends Rebound As Morgan Stanley Lifts Price Target To $625Traders UnionYesterday, 4:48 PMSaveMicrosoft launches 365 Premium with AI embedded throughout its productivity appsSA NewsYesterday, 4:13 PMSaveTech Voices: Microsoft on chips, 365-Copilot bundle; Qualcomm-ArmSA NewsYesterday, 2:12 PM3 CommentsSaveMicrosoft promotes Althoff to Commercial CEO as Nadella focuses on AI technical workSA NewsYesterday, 12:12 PMSaveXbox Game Pass gets makeover to include extra benefits and reflect price hike on top-tier planSA NewsYesterday, 11:02 AM2 CommentsSaveSouth Korea's Samsung and SK hynix join OpenAI’s Stargate projectSA NewsYesterday, 6:56 AM12 CommentsSaveSA analyst upgrades/downgrades: AAPL, QCOM, MSFT, BRK.BSA NewsTue, Sep. 308 CommentsSaveOpenAI unveils release of new Sora video editing appSA NewsTue, Sep. 302 CommentsSaveCiti sees big tech hyperscalers spending $2.8T by 2029SA NewsTue, Sep. 3017 CommentsSaveOpenAI's H1 revenue climbs 16% to $4.3 billion - reportSA NewsTue, Sep. 3028 CommentsSaveMore News And Analysis »SeasonalityDisplays mean and median monthly returns for MSFT in order to identify seasonal patterns.ChartBar chart with 2 data series.View as data table, ChartThe chart has 1 X axis displaying categories. The chart has 1 Y axis displaying Values. Data ranges from 0 to 0.Created with Highcharts 12.4.0ValuesMedianMeanEnd of interactive chart.YearJanFebMarAprMayJunJulAugSepOctNovDecYearJanFebMarAprMayJunJulAugSepOctNovDec+ Seasonality Stocks To Home PagePeople Also FollowSymbolLast PriceChangeAAPLApple Inc.255.45Post. 255.280.32%-0.07%AMZNAmazon.com, Inc.220.63Post. 221.000.48%0.17%NVDANVIDIA Corporation187.24Post. 186.940.35%-0.16%METAMeta Platforms, Inc.717.34Post. 718.78-2.32%0.20%TSLATesla, Inc.459.46Post. 461.383.31%0.42%CompareDividend Grades?GradeNow3M ago6M agoSafetyA+A+A+GrowthA+A+A+YieldD-DDConsistencyAAADividend Grades Beat The Market »Bulls SayBears SayCompany ProfileMicrosoft Corporation develops and supports software, services, devices, and solutions worldwide. The company’s Productivity and Business Processes segment offers Microsoft 365 Commercial, Enterprise Mobility + Security, Windows Commercial, Power BI, Exchange, SharePoint, Microsoft Teams, Security and Compliance, and Copilot; Microsoft 365 Commercial products, such as Windows Commercial on-premises and Office licensed services; Microsoft 365 Consumer products and cloud services, such as Microsoft 365 Consumer subscriptions, Office licensed on-premises, and other consumer services; LinkedIn; Dynamics products and cloud services, such as Dynamics 365, cloud-based applications, and on-premises ERP and CRM applications. Its Intelligent Cloud segment provides Server products and cloud services, such as Azure and other cloud services, GitHub, Nuance Healthcare, virtual desktop offerings, and other cloud services; Server products, including SQL and Windows Server, Visual Studio and System Center related Client Access Licenses, and other on-premises offerings; Enterprise and partner services, including Enterprise Support and Nuance professional Services, Industry Solutions, Microsoft Partner Network, and Learning Experience. The company’s Personal Computing segment provides Windows and Devices, such as Windows OEM licensing and Devices and Surface and PC accessories; Gaming services and solutions, such as Xbox hardware, content, and services, first- and third-party content Xbox Game Pass, subscriptions, and Cloud Gaming, advertising, and other cloud services; search and news advertising services, such as Bing and Copilot, Microsoft News and Edge, and third-party affiliates. It sells its products through OEMs, distributors, and resellers; and online and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.More...Full Company Profile »RevenueMore On Revenue »Earnings Per ShareMore On Earnings »Earnings EstimatesEarnings RevisionsBFY1 Up Revisions41FY1 Down Revisions36% Down94% UpMore On Earnings Revisions »ValuationFP/E Non-GAAP (FWD)33.30P/E GAAP (TTM)37.97Price/Book (TTM)11.21EV/Sales (TTM)13.73EV/EBITDA (TTM)24.71More On Valuation »GrowthProfitabilityA+Gross Profit Margin68.82%EBIT Margin45.62%Net Income Margin36.15%Return on Equity33.28%Return on Assets16.45%More On Profitability »MomentumCapital StructureMarket Cap$3.85TTotal Debt$112.18BCash$94.57BOther-Enterprise Value$3.87TTrading DataVolume22.63MAverage Volume (3 months)20.06MPrevious Close517.95Open514.80Shares Outstanding (Ticker)7.43BDividendsDividend Yield (FWD)0.70%Annual Payout (FWD)$3.64Payout Ratio24.34%5 Year Growth Rate (CAGR)10.23%Years of Growth20 YearsLatest Announced Dividend$0.91Ex-Dividend Date11/20/2025Payout Date12/11/2025FrequencyQuarterlyMore On Dividends »Dividend Growth HistoryMore On Dividend Growth »OwnershipPeersRiskShort Interest0.88%Shares Short65.24MDays to Cover3.3924M Beta0.98Altman Z Score8.64TechnicalsTitle10D SMA50D SMA200D SMASimple Moving Average512.13512.35450.94Last Price vs SMA+1.14%+1.09%+14.86%More On Moving Averages »TranscriptsMicrosoft Corporation (MSFT) Presents At Goldman Sachs Communacopia + Technology Conference 2025 TranscriptSA TranscriptsWed, Sep. 10SaveMicrosoft Corporation (MSFT) Presents at Deutsche Bank's 2025 Technology Conference TranscriptSA TranscriptsThu, Aug. 28SaveMicrosoft Corporation (MSFT) Q4 2025 Earnings Call TranscriptSA TranscriptsWed, Jul. 302 CommentsSaveMicrosoft Corporation (MSFT) Q3 2025 Earnings Call TranscriptSA TranscriptsWed, Apr. 30SaveMicrosoft Corporation (MSFT) Presents at Morgan Stanley TMT Conference (Transcript)SA TranscriptsTue, Mar. 041 CommentSaveSee All Transcripts »Investor PresentationsMicrosoft Corporation 2025 Q2 - Results - Earnings Call PresentationWed, Jan. 294 CommentsSaveMicrosoft Corporation 2024 Q4 - Results - Earnings Call PresentationTue, Jul. 30, 20243 CommentsSaveMicrosoft Corporation 2024 Q2 - Results - Earnings Call PresentationTue, Jan. 30, 2024SaveMicrosoft Corporation 2023 Q2 - Results - Earnings Call PresentationTue, Jan. 24, 2023SaveMicrosoft Corporation 2023 Q1 - Results - Earnings Call PresentationTue, Oct. 25, 2022SaveSee All Investor Presentations »SEC FilingsType:AllMicrosoft Corporation (MSFT) - 8-K - Current reportSEC FilingsTue, Sep. 30Microsoft Corporation (MSFT) - 4 - Statement of Changes in Beneficial OwnershipSEC FilingsWed, Sep. 17Microsoft Corporation (MSFT) - 4 - Statement of Changes in Beneficial OwnershipSEC FilingsWed, Sep. 17Microsoft Corporation (MSFT) - 4 - Statement of Changes in Beneficial OwnershipSEC FilingsWed, Sep. 17Microsoft Corporation (MSFT) - 4 - Statement of Changes in Beneficial OwnershipSEC FilingsWed, Sep. 17See All SEC Filings »Press ReleasesSee All Press Releases »Income StatementBalance SheetCash Flow StatementLong Term SolvencyTotal Debt / Equity (MRQ)32.66%Total Debt / Capital (MRQ)24.62%LT Debt / Equity (MRQ)29.29%LT Debt / Total Capital (MRQ)22.08%Total Liabilities / Total Assets (MRQ)44.51%Looking For The Perfect Gift?You can now buy 1 year of Seeking Alpha Premium for whomever you like.Gift Premium16 Investing Groups Covering MSFT »Add Custom NotesRatings Summary?NameRatingScoreSA AnalystsBuyRating: Buy4.00Wall StreetStrong BuyRating: Strong Buy4.74QuantHoldRating: Hold3.48Quant Ranking?SectorInformation TechnologyIndustrySystems SoftwareRanked Overall745 out of 4313Ranked in Sector98 out of 540Ranked in Industry9 out of 46Quant Ratings Beat The Market »Dividend Grades?GradeNow3M ago6M agoSafetyA+A+A+GrowthA+A+A+YieldD-DDConsistencyAAADividend Grades Beat The Market »Looking For The Perfect Gift?You can now buy 1 year of Seeking Alpha Premium for whomever you like.Gift PremiumSeeking Alpha - Power to InvestorsPower to InvestorsFollow usDownload appAccountAccount SettingsManage My PortfolioPrivacyCreate PortfolioAlert PreferencesSubscriptionsPremium & ProGroup SubscriptionsAlpha PicksAbout Alpha PicksFREE NewslettersInvesting GroupsLearn About Investing GroupsMost PopularFree TrialsTop RatedDividend InvestingValue InvestingOptions TradingGrowth StocksBiotech InvestingTech StocksQuantitative InvestingLearnInvesting ResourcesInvesting EducationInvesting StrategiesRetirement InvestingStock Market SectorsStock Market Holidays & HoursAfter Hours TradingPortfolio ManagementCryptocurrencyDividend InvestingPortfolio StrategyFixed IncomeRetirementIPO'sPodcastsVideo HubEventsEditors' PicksStock AnalysisStock IdeasLong IdeasStock Upgrades & DowngradesEditors' PicksQuick Picks & ListsEmerging MarketsStock ScreenerStocks by QuantTop StocksTop Quant Dividend StocksHigh Dividend Yield StocksTop Dividend StocksETFs & FundsETF ScreenerETF AnalysisETF GuideMutual FundsClosed End FundsEditors' PicksDividendsDividend Stock NewsREITsDividend IdeasDividend StrategyDividend Quick PicksEditors' PicksAnalysis by SectorEnergyCommunication ServicesReal EstateConsumer StaplesTechBasic MaterialsHealthcareConsumerUtilitiesFinancialsIndustrialsStock Comparison ToolsFAANG StocksGold ETFsCash EquivalentsBig Bank StocksBig Pharma StocksRetail StocksTop IndexesDow JonesS&P 500NasdaqGoldBitcoinMarket OutlookToday's MarketUS EconomyGold & Precious MetalsCommoditiesForexEditors' PicksCryptocurrencyMarket DataBond ETFsCommodity ETFsCountry ETFsCurrency ETFsDividend ETFsEmerging Market ETFsGlobal and Regional ETFsGrowth vs. Value ETFsMarket Cap ETFsReal Estate ETFsSector ETFsETF StrategiesSmart BetaThemes & Subsectors ETFsCryptocurrencyMarket NewsTop NewsTrending NewsOn the MoveMarket PulseGlobal MarketsNotable CallsBuybacksCommoditiesCryptocurrencyDebt/Share IssuanceDividends - StocksDividends - FundsGuidanceIPOsSPACsBudget & RegulationJobs & EmploymentPoliticsM&AUS EconomyWall Street BreakfastNews by SectorConsumerEnergyFinancialsHealthcareTechEarningsEarnings CalendarEarnings NewsEarnings AnalysisEarnings Calls TranscriptsContact usSubscription Support: 1-347-509-6837Contact UsAbout UsGroup SubscriptionsAffiliate ProgramCareersSitemapRSS FeedTerms Of UsePrivacyMarket Data Sources© 2025 Seeking AlphaThe last Virtual Analyst Report was generated on or before 9/27/2025.BackVirtual Analyst ReportGenerated on 10/02/2025 12:01 AMFollow MSFTMSFT - Microsoft CorporationHoldQuant RatingMarket Cap$3.85TEPS Growth (FWD)15.64%P/E (FWD)33.30IndustrySystems SoftwareDividend Yield (FWD)0.70%Dividend FrequencyQuarterlyEx-Dividend Date (Last)11/20/2025Annual Payout (FWD)$3.64Copy URLSharePrintCompany Description\nMicrosoft Corporation, founded in 1975, is a global leader in developing and supporting a wide range of software, services, devices, and solutions. Headquartered in Redmond, Washington, the company operates through several key segments: Productivity and Business Processes, Intelligent Cloud, and Personal Computing. Microsoft's Productivity and Business Processes segment includes offerings such as Microsoft 365 Commercial, Dynamics 365, LinkedIn, and Copilot, which cater to both commercial and consumer needs. The Intelligent Cloud segment is anchored by Azure, which provides a broad range of cloud services, including AI and data analytics platforms. Additionally, this segment encompasses GitHub, Nuance Healthcare, and various server products. The Personal Computing segment encompasses Windows and Devices, including Surface products, gaming services through Xbox, and search and news advertising via Bing.\n\nMicrosoft is actively expanding its cloud and AI capabilities, as evidenced by its substantial investments in data centers and partnerships, such as its collaboration with OpenAI. The company's focus on AI integration is evident in products like Microsoft 365 Copilot and Azure AI services. Microsoft operates over 400 data centers across 70 regions worldwide, making it a leader in cloud infrastructure. The company's strategic investments in AI and cloud technologies underscore its commitment to long-term growth and innovation.\nCompetitors and Unique Value\nMicrosoft faces competition from several notable companies that offer similar products and services. Key competitors include:\nAmazon Web Services (AWS): A leading provider of cloud computing services, AWS is a primary competitor to Microsoft's Azure platform.\nGoogle Cloud: Part of Alphabet Inc., Google Cloud competes with Azure in cloud services and AI technologies.\nOracle Corporation: Known for its cloud and database services, Oracle competes with Microsoft in the enterprise cloud market.\n\nMicrosoft's unique value proposition lies in its extensive integration of AI across its product suite, strong ecosystem of services like Microsoft 365 and Azure, and its robust enterprise solutions. The company's strategic partnerships, such as with OpenAI, enhance its AI capabilities, providing a competitive edge in the rapidly evolving tech landscape.\nSeeking Alpha Quant Rating Explanation\nMSFT is rated Hold. While the company displays exceptional profitability and solid growth, its valuation appears stretched, and momentum is mixed.\nValuationFGrowthC-ProfitabilityA+MomentumB-RevisionsBSector Metrics Comparative Analysis:Valuation: MSFT's valuation is notably high, with its Price to Sales ratio at 14 compared to the sector median of 4, indicating a premium valuation. This suggests the stock might be overvalued versus its peers.\nGrowth: MSFT demonstrates robust growth metrics, with Year-over-Year Revenue Growth of 15%, significantly above the sector's 7%. This growth trajectory underscores MSFT's successful expansion in the market.\nProfitability: MSFT boasts exceptional profitability, with a Net Income Margin of 36%, substantially higher than the sector's 4%. This indicates efficient operations and strong profit conversion from sales.\nMomentum: MSFT's momentum is mixed, with a 1-year price performance of 20%, outperforming the sector's 10%, but the recent 3-month performance lags behind the sector.\nRevisions: Analysts have shown optimism, with 41 upward EPS revisions and only 3 downward in the last 90 days, suggesting confidence in MSFT's earnings potential.\n\nSummary  \n\nMSFT exhibits strong profitability and growth, driving positive sentiment among analysts. However, its high valuation and mixed momentum lead to a Hold rating.\nPositives raised by analysts on Seeking Alpha\n\n\nMicrosoft is heavily investing in data centers and AI infrastructure, committing $7.3 billion in Wisconsin, which supports long-term cloud and AI growth. Read more\n\n\nAzure's growth accelerated to 39%, solidifying Microsoft's leadership in AI infrastructure and providing nearly 26% upside over the next 1-2 years. Read more\n\n\nMicrosoft's Azure cloud growth is projected to continue at a strong pace, supported by its leading market position and strategic partnership with OpenAI. Read moreRead more analysis on MSFT Concerns raised by analysts on Seeking Alpha\n\n\nMicrosoft's shares are considered overbought, with expectations too high, as intensified competition in cloud services from Amazon and Google threatens future growth. Read more\n\n\nDespite strong fundamentals, Microsoft's current share price reflects high expectations for sustained abnormal returns, making its risk-reward profile less compelling. Read more\n\n\nThe AI market, crucial for Microsoft's growth, is seen as potentially entering a bubble, with no clear new catalysts on the horizon to justify the high valuation. Read moreRead more analysis on MSFTMore on MSFTInvesting Groups discussing MSFTTop rated stocks in the industryRead more analysis on MSFTAbout Seeking Alpha’s Virtual Analyst Reports\n  This report integrates all the crowd-sourced wisdom of Seeking Alpha analysis and our proprietary quant model into one easy-to-read report.\n\n  AI tools frequently struggle to provide reliable guides for investors, because the sources on which they base their answers or recommendations lack a proven track record in stock picking, and are frequently written by journalists or marketers rather than investors.\n\n  In contrast, Seeking Alpha uses generative AI to create Virtual Analyst Reports exclusively from our own trusted, editor-approved content and financial data. We use unique sources exclusive to Seeking Alpha. These sources have excellent stock picking track records, and are produced by investors, for investors.\n\n  Our main sources are Seeking Alpha’s quant ratings and analyst articles. Both of these have long track records of strong stock picking performance. Here’s the track record of our quant ratings. And here’s the track record of the ratings from our analysts’ articles, which illustrates “the wisdom of the crowd” at the heart of Seeking Alpha’s crowd-sourced investment analysis.\nTop Quant Rating328%SA Analyst171%S&P 50093%ChartLine chart with 3 lines.View as data table, ChartThe chart has 1 X axis displaying Time. Data ranges from 2019-10-23 20:00:00 to 2025-09-29 20:00:00.The chart has 1 Y axis displaying values. Data ranges from -35.51337812243312 to 327.67001885012866.Created with Highcharts 12.4.0Apr. 23, 2020Apr. 21, 2021Apr. 18, 2022Apr. 17, 2023Apr. 15, 2024Apr. 14, 2025-60%-30%0%30%60%90%120%150%180%210%240%270%300%330%360%End of interactive chart.\n  The result is that our Virtual Analyst Reports share the same predictive strength as our Quant ratings, and summarize valuable insights from Seeking Alpha analysts, who have also beaten the market as a group.\nYour feedback matters to usSubmitVirtual Analyst Report FAQ >>Virtual Analyst Report FAQ >>Disclosure: The Virtual Analyst Report is an up-to-date easy-to-read summary compilation of content available on the Seeking Alpha website, including research analysis created by third parties and ratings set by the Quant system. The summary is written by a commercial general-purpose language model (LLM), and has not been curated or reviewed by editors. Due to the inherent limitations in using AI tools, please consider the probability of error. The accuracy, completeness or timeliness of the report cannot be guaranteed. It is generated on the date indicated at the top of the page, based on the content available on the Seeking Alpha website at that time, and is automatically updated as new content becomes available on the site. It offers a concise overview of a company, an explanation of the stock's Quant Ratings and a short summary of bullish and bearish research analysis available on Seeking Alpha with respect to such stock. Research analysis is automatically selected by the AI tool based on relevant dates and overall analyst ratings. The report does not consider any other information or perform any independent analysis.\n\n        The Virtual Analyst Report is intended for informational purposes only and should not be construed as financial advice or a recommendation for any investment strategy. Any views or opinions expressed may not reflect those of Seeking Alpha as a whole. Seeking Alpha does not take account of your objectives or financial situation and does not offer any personalized investment advice. Analysts are third parties that include both professional and individual investors who may not be licensed or certified by any institute or regulatory body. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.\n\n        We encourage you to provide your feedback on the usefulness of this summary using the feedback input field above.BackGenerated 10/02/25MSFT - Microsoft CorporationHoldGenerated 10/02/25To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.\n\n\n<iframe height=\"0\" src=\"https://www.googletagmanager.com/ns.html?id=GTM-MSK9R8B\" style=\"display:none;visibility:hidden\" title=\"google-tag-manager\" width=\"0\"></iframe><img alt=\"\" src=\"/_sa_track/samw/noscript?noscript[disabled]=true\">\n\n\n\n\n\n\n\n\n  \n  \n  \n  \n  \n  \n  \n  \n\n\n!function(b,e,f,g,a,c,d){b.fbq||(a=b.fbq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._fbq||(b._fbq=a),a.push=a,a.loaded=!0,a.version=\"2.0\",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,\"script\",\"https://connect.facebook.net/en_US/fbevents.js\");fbq(\"init\",\"228550053985270\");fbq(\"track\",\"PageView\");\n<img height=\"1\" width=\"1\" style=\"display:none\" src=\"https://www.facebook.com/tr?id=228550053985270&amp;ev=PageView&amp;noscript=1\">\n\n!function(b,e,f,g,a,c,d){b.saq||(a=b.saq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._saq||(b._saq=a),a.push=a,a.loaded=!0,a.version=\"1.0\",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,\"script\",\"https://tags.srv.stackadapt.com/events.js\");saq(\"ts\",\"blaF1FtON6tR_IxV4MjJrA\");!function(a,b){var e=\"0024c043618e075e435f95a5ef5ef386f5\";if(a.obApi)b=function(d){return Object.prototype.toString.call(d)===\"[object Array]\"?d:[d]},a.obApi.marketerId=b(a.obApi.marketerId).concat(b(e));else{var c=a.obApi=function(){c.dispatch?c.dispatch.apply(c,arguments):c.queue.push(arguments)};c.version=\"1.1\";c.loaded=!0;c.marketerId=e;c.queue=[];a=b.createElement(\"script\");a.async=!0;a.src=\"//amplify.outbrain.com/cp/obtp.js\";a.type=\"text/javascript\";b=b.getElementsByTagName(\"script\")[0];b.parentNode.insertBefore(a,\nb)}}(window,document);obApi(\"track\",\"PAGE_VIEW\");\n",
      "url": "https://seekingalpha.com/symbol/MSFT/virtual_analyst_report"
    }
  ]
}